No products in the cart.
Cat:GMP-MPV-Tg03-nAb
* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry
Description
Cat No.
GMP-MPV-Tg03-nAb001, GMP-MPV-Tg03-nAb002, GMP-MPV-Tg03-nAb003, GMP-MPV-Tg03-nAb004, GMP-MPV-Tg03-nAb005
Target
L1
Product Name (Neutralizing antibody Name)
Anti-MPV (L1) human monoclonal neutralizing antibody (IgG1)
Source (Expression Host)
Mammalian (human cell)
Isotypes
human IgG1
Bioactivity validation
Validated in Monkeypox virus (MPV) [F-Target cloumn] antigen protein binding affnity.ELISA validated as capture antibody and detection antibody. Pair recommendation with other [F-Target cloumn] antibodies in [F-Target cloumn] level test of Monkeypox virus (MPV) infectious diseases.
Tag
hFc
Products description
Anti-MPV (L1) human monoclonal neutralizing antibody (IgG1) is a potency validated Monkeypox virus (MPV) neutralizing antibody. It is a human IgG1 antibody produced by Mammalian (human cell). The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other L1 antibodies.
Reconized/Reactive Species
Human
Purity
Purity: ≥95% (SDS-PAGE)
Application
This antibodies can either act as positive control in Monkeypox virus (MPV) related vaccines and neutralizing antibodies discovery and development, or act as a benchmark in Monkeypox virus (MPV) neutralization potency assay. ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT.
Formulation
Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage
Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.
